Trial Profile
Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Angina pectoris; Coronary artery disease
- Focus Pharmacodynamics
- 12 Mar 2013 New trial record